7-(4-Chlorobutoxy)quinolin-2(1H)-one CAS 913613-82-8 Purity >98.0% (HPLC) Brexpiprazole Intermediate Factory

Incazelo emfushane:

Igama: 7-(4-Chlorobutoxy)quinolin-2(1H)-one

I-CAS: 913613-82-8

Ubumsulwa: >98.0% (HPLC)

Ukubukeka: Okuphuzi Okuphaphathekile ukuya kokuphaphathekile okuBeige Okuqinile

I-Intermediate ye-Brexpiprazole (CAS: 913611-97-9)

E-Mail: alvin@ruifuchem.com

Thumela i-imeyili kithi

Imininingwane Yomkhiqizo

Imikhiqizo Ehlobene

Omaka bomkhiqizo

Incazelo:

I-Ruifu Chemical Supply Brexpiprazole Intermediates
I-Brexpiprazole CAS 913611-97-9
I-7-Hydroxyquinolinone CAS 70500-72-0
4-Bromobenzo[b]thiophene CAS 5118-13-8
1-(1-Benzothiophen-4-yl)piperazine Hydrochloride CAS 913614-18-3
7-(4-Chlorobutoxy)quinolin-2(1H)-one CAS 913613-82-8
4-Chlorobenzo[b]thiophene CAS 66490-33-3

Chemical Properties:

Igama Lekhemikhali	7-(4-Chlorobutoxy)quinolin-2(1H)-one
Omqondofana	7-(4-Chlorobutoxy)-1H-Quinolin-2-one;I-Brexpiprazole Ukungcola 23
Inombolo ye-CAS	913613-82-8
Inombolo yeCAT	I-RF-PI1980
Isimo Sesitoko	Esitokweni, Isikali Sokukhiqiza Sifinyelela Kumathani
I-Molecular Formula	I-C13H14ClNO2
Isisindo samangqamuzana	251.71
Iphuzu elibilayo	460.8±45.0℃
Ukuminyana	1.216±0.06 g/cm3
Ibhrendi	I-Ruifu Chemical

Imininingwane:

Into	Imininingwane
Ukubukeka	Okuphuzi Okuphaphathekile kuya ku-Pale Beige Okuqinile
Ukuhlanzeka / Indlela Yokuhlaziya	>98.0% (HPLC)
I-Infrared Spectrum	Ivumelana Nesakhiwo
I-NMR	Ivumelana Nesakhiwo
Izinga Lokuhlola	I-Enterprise Standard
Ukusetshenziswa	Okumaphakathi / Ukungcola kwe-Brexpiprazole (CAS: 913611-97-9)

Iphakheji nesitoreji:

Iphakheji: Ibhodlela, isikhwama se-Aluminium foil, 25kg/Cardboard Drum, noma ngokwemfuneko yekhasimende

Isimo Sesitoreji:Gcina ezitsheni ezivaliwe endaweni epholile neyomile;Vikela ekukhanyeni nakumswakama

Izinzuzo:

I-FAQ:

Isicelo:

7-(4-Chlorobutoxy)quinolin-2(1H)-one (CAS: 913613-82-8) ukungcola okumaphakathi / kwe-Brexpiprazole (CAS: 913611-97-9).I-Brexpiprazole iyisidakamizwa se-atypical antipsychotic.Kuyi-D2 dopamine partial agonist ebizwa nge-serotonin-dopamine activity modulator (SDAM).Umuthi uthole imvume ye-FDA ngomhlaka-13 Julayi 2015 yokwelashwa kwe-schizophrenia, kanye nokwelashwa okuhlanganisayo kokucindezeleka.Nakuba i-Brexpiprazole yehlulekile ezivivinyweni zomtholampilo zeSigaba II ze-ADHD, i-Brexpiprazole yakhelwe ukuhlinzeka ngokusebenza okuthuthukisiwe nokubekezelelana (isb., i-akathisia encane, ukungahlaliseki kanye/noma ukuqwasha) phezu kwemithi yokwengeza emisiwe ye-depressive disorder (MDD).